VWD Panel Triage: The ratio of Activity (RCo) to Antigen (Ag) is the primary engine for differentiating quantitative (Type 1) from qualitative (Type 2) defects.
Input Panel (Units: %)
Awaiting Lab Values
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Interpreting VWF Antigen (VWF:Ag) and VWF Activity (VWF:RCo) results in patients with suspected VWD.
Differentiating between Quantitative (Type 1) and Qualitative (Type 2) von Willebrand Disease.
Evaluating Factor VIII levels in the context of VWF carrier function.
Timing and Stress
VWF is an acute phase reactant. Levels may be falsely elevated (masking VWD) during pregnancy, infection, or after exercise. Repeat testing is often required.
Section 2
Formula & Logic
VWF:RCo to VWF:Ag Ratio
A ratio of < 0.6 strongly suggests a qualitative defect (Type 2 VWD), as the functioning protein is significantly lower than the total amount of protein present.
VWD Classification Criteria
Type
VWF:Ag
VWF:RCo
Ratio (RCo/Ag)
Description
Type 1
Low (< 30-50%)
Low
> 0.6
Partial quantitative deficiency.
Type 2
Low or Normal
Very Low
< 0.6
Qualitative functional defect.
Type 3
Absent (< 5%)
Absent
N/A
Severe total deficiency.
Section 3
Pearls/Pitfalls
The 'Low VWF' Grey Zone
Recent ASH/ISTH/WFH guidelines define VWD as VWF:RCo < 30%. Levels between 30% and 50% are categorized as "Low VWF," where patients may still have bleeding risks but may not meet the formal genetic criteria for VWD.
Blood Type O Effect
Individuals with Blood Type O naturally have ~25% lower VWF levels than non-O individuals. Reference ranges should strictly consider ABO blood type for accurate diagnosis.
Section 4
Evidence Appraisal
Primary Strategy
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.
James PD et al. • Blood Advances. 2021;Current international gold standard.